0001437749-23-002340.txt : 20230202 0001437749-23-002340.hdr.sgml : 20230202 20230202130544 ACCESSION NUMBER: 0001437749-23-002340 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230131 FILED AS OF DATE: 20230202 DATE AS OF CHANGE: 20230202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Dong CENTRAL INDEX KEY: 0001920163 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 23579841 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA, LTD. STREET 2: 400 ALEXANDER PARK DRIVE, 4TH FLOOR CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 rdgdoc.xml FORM 4 X0306 4 2023-01-31 0001668243 UroGen Pharma Ltd. URGN 0001920163 Kim Dong 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 1 Chief Financial Officer Restricted Stock Units 2023-01-31 4 A 0 10000 0 A Ordinary Shares 10000 10000 D Employee Stock Option (right to buy) 10.39 2023-01-31 4 A 0 38000 0 A 2033-01-31 Ordinary Shares 38000 38000 D Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. 1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. /s/ Jason D. Smith, Attorney-in-Fact 2023-02-02